FREE Shipping on Canadian Orders Over $200


Key Features

  • DGL stimulates and/or accelerates the factors that protect against ulcers including increasing the production of mucin – the protective coating in the stomach and intestines.
  • Found to be an effective anti-ulcer compound 
  • Shown to be more effective than either Tagamet, Zantac or antacids in both short-term treatment and maintenance therapy of gastric and duodenal ulcers
  • composed of several flavonoids that have been shown to inhibit H. pylori.



Each Chewable tablet contains:
Deglycyrrizinated Licorice (DGL)        380 mg
Glycine                                                150 mg


Suggested Usage

2 tablets between each meal or as recommended by a health care practitioner.


As DGL has been shown to reduce the gastric bleeding caused by aspirin, DGL is strongly indicated for the prevention of gastric ulcers in patients requiring long-term treatment with ulcer-causing drugs, such as aspirin, other NSAIDs (e.g., ibuprofen, piroxicam, indomethacin, and dicofenac), and corticosteroids (e.g., prednisone).

Legal Disclaimer

The information in this communication has not been evaluated by Health Canada nor the FDA and is not intended to treat, diagnose, cure or prevent any disease. This information is not intended as a substitute for the advice or medical care of a qualified health care professional and you should seek the advice of your health care professional before undertaking any dietary or lifestyle changes. The material provided in this communication is for educational purposes only. Every effort is made to ensure this information is accurate and as up to date as possible.


Related Items